Home / Business and Economy / Green Plains Stock Soars on UBS Target Hike
Green Plains Stock Soars on UBS Target Hike
18 Jul
Summary
- UBS significantly raised Green Plains's stock target to $20.
- Second-quarter EBITDA estimate jumped to $93 million.
- Full-year 2026 EBITDA forecast more than doubled to $283 million.
Shares of biorefining company Green Plains experienced a notable increase of 9.1% during afternoon trading on **2026-07-18T01:15:18+00:00**. This surge followed an announcement by UBS, which elevated its price target for the stock to $20 from a previous $12.
Despite maintaining a Neutral rating, UBS substantially revised its financial outlook for Green Plains. The firm's second-quarter EBITDA estimate was raised to $93 million, a significant jump from the prior $36 million projection. Furthermore, the full-year 2026 EBITDA forecast for the renewable energy company was dramatically increased to $283 million, up from $149 million, signaling a considerably brighter profit outlook.
This upward revision has pushed Green Plains's stock to a new 52-week high. The company has seen an 83.3% gain year-to-date. However, investors who bought shares five years ago would currently see a diminished return on their investment.
